Logo

American Heart Association

  11
  0


Final ID: MP2590

Venous Thromboembolism in Female Hospitalizations with Intrauterine Devices (IUDs)

Abstract Body (Do not enter title and authors here): Background: The association between intrauterine device (IUD) use and pulmonary embolism (PE) risk in hospitalized females of reproductive age is understudied. This study assesses the risk of acute PE and deep vein thrombosis (DVT) in this population.

Methods: Using the National Inpatient Sample (2016–2022), we analyzed 6,441,068 females aged 18–50 years, categorized by IUD use (n=11,930, ICD-10-CM code Z97.5) or non-use. Multivariate logistic regression adjusted for confounders, reporting odds ratios (ORs) and 95% confidence intervals (CIs) for predictors of acute PE and DVT. Statistical significance was set at p<0.05.

Results: Among 11,930 females with IUDs, 265 (2.22%) had acute PE, and 110 (0.92%) had DVT. Females with IUDs had significantly higher odds of acute PE (OR 2.68, 95% CI 2.03–3.53, p<0.01), DVT (OR 1.66, 95% CI 1.07–2.57, p<0.01), and a composite PE/DVT outcome (OR 2.88, 95% CI 1.72–4.83, p<0.01) compared to those without IUDs.

Conclusion: IUD use is associated with a 168% increased risk of acute PE and a 66% increased risk of DVT in hospitalized females of reproductive age. The reliance on ICD-10 codes, which do not distinguish between hormonal and copper IUDs, may underestimate the true thrombotic risk. These findings highlight the need for thorough counseling on thrombotic risks during IUD placement and further research to clarify IUD-specific risks and optimize venous thromboembolism prevention strategies during hospitalization.
  • Rajotia, Arush  ( University of California Riverside , Redlands , California , United States )
  • Vasavada, Advait  ( University of Nebraska , Omaha , Nebraska , United States )
  • Chen, Mayting  ( Western University Health Sciences , Pomona , California , United States )
  • Kalaiger, Abdul Mukhtadir  ( Montefiore Medical Center , New York , New York , United States )
  • Author Disclosures:
    Arush Rajotia: DO NOT have relevant financial relationships | Advait Vasavada: DO NOT have relevant financial relationships | Mayting Chen: DO NOT have relevant financial relationships | Abdul Mukhtadir Kalaiger: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Advances in Venous Thromboembolic Disease

Monday, 11/10/2025 , 01:45PM - 02:45PM

Moderated Digital Poster Session

More abstracts on this topic:
Associations Between Paraben Exposure and Cardiometabolic Outcomes in Pediatric Populations: A Systematic Review

Chinerman Deanna, Lungu Ana, Henderson Melanie, Van Hulst Andraea, Chevrier Jonathan, Schuster Tibor, Barnett Tracie

Growth Differentiation Factor 15 is a Novel Cardiac Hormone that Causes Cachexia in Heart Failure

Trujillo Maya, Gupta Ria, Lee Da Young, Jiao Zhe, Berhanu Samuel, Antolic Andrew, Weitzmann M. Neale, Burke Michael

More abstracts from these authors:
Wake up call for the need of standardized medical management for Myocardial Infarction with non-obstructive coronary arteries (MINOCA): A Meta-analysis

Mohan Ayushi, Rajotia Arush, Bagheri Sina, Bhattar Keshav, Reddy Srivaibhav, Reddy Krishna Theja, Ho Andrew

Real-world Outcomes of Nicotine Replacement Therapy in Acute Coronary Syndrome

Dhaliwal Jasninder, Sekhon Manraj, Rajotia Arush, Ramphul Kamleshun, Singh Swaiman

You have to be authorized to contact abstract author. Please, Login
Not Available